Download PDF

Register to download the report. Already a member?

 
 
Sign Up

Or

67053 1513184208HCLSReviewBulgariaDecember2017.pdf
Energy Boardroom

First filing for Takeda's once-weekly DPP-4 inhibitor but prospects limited?

10.03.2014 / Scripintelligence

The submission also appears to be the first worldwide for a once-weekly DPP-4 inhibitor, a class now administered once a day, and assuming normal regulatory review times in Japan may result in an approval there in around a year's time.

LATEST ISSUE

DOWNLOAD

Most Read

X
Download PDF

First Name:

Last Name:

Company:

Position:

Country:

Email: